Canine Infl H3N8 Kv

Verify with FDA CVM →

16 adverse event reports submitted to the FDA

Important: Adverse event reports do not establish that a drug caused or contributed to the event. Consult your veterinarian before making treatment decisions.
16
Total Reports
5
Deaths Reported
3120.0%
Death Rate

Active Ingredients

Canine Infl H3N8 Kv

Administration Routes

Subcutaneous

Species Affected

Dog 16

Most Affected Breeds

Terrier (unspecified) 2
Coton de Tuléar 2
Retriever - Labrador 1
Terrier - Yorkshire 1
Terrier - Jack Russell 1
Mastiff 1
Doberman Pinscher 1
Havanese 1
Shih Tzu 1
Boxer (German Boxer) 1

Most Reported Reactions

Lethargy (see also Central nervous system depression in 'Neurological') 6
Diarrhoea 3
Death 3
Emesis (multiple) 3
Inappropriate urination 2
Polyuria 2
Hyperphosphataemia 2
Anorexia 2
Death by euthanasia 2
Anaemia NOS 2
Drug administration duration too long 2
Vomiting 2

Outcome Breakdown

Ongoing
6 (37.5%)
Outcome Unknown
3 (18.8%)
Died
3 (18.8%)
Recovered/Normal
2 (12.5%)
Euthanized
2 (12.5%)

Data Summary

Metric Value
Total adverse event reports 16
Reports involving death 5
Case-fatality rate (reported events) 3120.0%
Distinct species in reports 1
Distinct breeds in reports 14
Distinct reactions reported 20
Active ingredients on file 1

Source: FDA Center for Veterinary Medicine — Adverse Event Reporting (CVM AER). Counts reflect voluntary reports only.

Canine Infl H3N8 Kv Adverse Event Insights

The FDA Center for Veterinary Medicine database currently holds 16 adverse event reports referencing Canine Infl H3N8 Kv, including 5 reports in which the animal died — a 3120.0% case-fatality figure among reported events only, not a population-level mortality rate. Active ingredient on file: Canine Infl H3N8 Kv. Reported administration route is Subcutaneous. These numbers reflect voluntary submissions from pet owners, veterinarians, and manufacturers and therefore under-represent mild events and over-represent severe ones — a pattern the FDA has documented repeatedly for pharmacovigilance datasets.

The species most frequently named in Canine Infl H3N8 Kv reports are Dog (16 reports), with Dog accounting for the largest share. Within those species, Terrier (unspecified) (2), Coton de Tuléar (2), Retriever - Labrador (1) appear most often — though breed popularity and ownership density shape these counts as much as any drug-specific sensitivity. This distribution matters because the same active ingredient can behave very differently across body sizes, ages, and species physiology.

The most commonly reported clinical signs associated with Canine Infl H3N8 Kv are Lethargy (see also Central nervous system depression in 'Neurological') (6), Diarrhoea (3), Death (3), Emesis (multiple) (3). Of the 16 reports with a coded outcome, Ongoing is the leading category at 37.5%. Because FDA adverse event data describes correlation rather than causation, these figures are best used to frame informed questions with a veterinarian and to compare reporting patterns across related products — not as a standalone safety verdict on Canine Infl H3N8 Kv.

Source: FDA Center for Veterinary Medicine — Adverse Event Reports FDA Center for Veterinary Medicine — Adverse Event Reports Data reflects voluntary submissions and may not represent actual incidence rates

Related

Data sourced from official AKC, AVMA, ACVO, and breed-club veterinary references. See our methodology for details. Retrieved and formatted by PlainBreed Editorial